Autor Título Original / Colaboración Selecciona una opción Original Colaboración Año Selecciona un año2015201620172018201920202021202220232024 Cuartil Selecciona un cuartilD1Q1Q2Q3Q4 Tipo Selecciona un tipo#N/DArticleArtículoBook ChapterBook ReviewClinical TrialCommentaryCorrectionData PaperEditorialEditorial MaterialLetterProceedings PaperReprintReview Revista A Risk-Adapted Approach to Patients with Stage I Seminoma according to the Status of Rete Testis: The Fourth Spanish Germ Cell Cancer Group Study Autores: Aparicio, J; Sanchez-Munoz, A; Guma, J; Domenech, M; Meana, JA; Garcia-Sanchez, J; Bastus, R; Girones, R; Gonzalez-Billalabeitia, E; Sagastibelza, N; Ochenduszko, S; Sanchez, A; Terrasa, J; Germa-Lluch, JR; del Muro, XG Could the Addition of Cetuximab to Conventional Radiation Therapy Improve Organ Preservation in Those Patients With Locally Advanced Larynx Cancer Who Respond to Induction Chemotherapy? An Organ Preservation Spanish Head and Neck Cancer Cooperative Group Phase 2 Study Autores: Mesia, R; Garcia-Saenz, JA; Lozano, A; Pastor, M; Grau, JJ; Martinez-Trufero, J; Lambeaz, J; Martinez-Galan, J; Mel, JR; Gonzalez, B; Vazquez, S; Manos, M; Taberna, M; Cirauqui, B; del Barco, E; Casado, E; Rubio-Casadevall, J; Rodriguez-Jaraiz, A; Cruz, JJ Phase II trial of dacomitinib, a pan-human EGFR tyrosine kinase inhibitor, in recurrent glioblastoma patients with EGFR amplification Autores: Sepulveda-Sanchez, JM; Vaz, MA; Balana, C; Gil-Gil, M; Reynes, G; Gallego, O; Martinez-Garcia, M; Vicente, E; Quindos, M; Luque, R; Ramos, A; Ruano, Y; Perez-Segura, P; Benavides, M; Sanchez-Gomez, P; Hernandez-Lain, A Multidisciplinary management of head and neck cancer: First expert consensus using Delphi methodology from the Spanish Society for Head and Neck Cancer (part 1) Autores: Manos, M; Giralt, J; Rueda, A; Cabrera, J; Martinez-Trufero, J; Marruecos, J; Lopez-Pousa, A; Rodrigo, JP; Castelo, B; Martinez-Galan, J; Arias, F; Chaves, M; Herranz, JJ; Arrazubi, V; Baste, N; Castro, A; Mesia, R Gemcitabine-erlotinib versus gemcitabine-erlotinib-capecitabine in the first-line treatment of patients with metastatic pancreatic cancer: Efficacy and safety results of a phase IIb randomised study from the Spanish TTD Collaborative Group Autores: Irigoyen, A; Gallego, J; Ponce, CG; Vera, R; Iranzo, V; Ales, I; Areevalo, S; Pisa, A; Martin, M; Salud, A; Falco, E; Saenz, A; Mozo, JLM; Pulido, G; Galaan, JM; Pazo-Cid, R; Rivera, F; Garcia, TG; Serra, O; Parra, EMF; Hurtado, A; Reina, MJG; Gomez, LJL; Esther, MOW; Benavides, M; Aranda, E Pancreatic ductal adenocarcinoma: metastatic disease Autores: Martin, AJM; Adeva, J; Martinez-Galan, J; Reina, JJ; Hidalgo, M Results of a multicenter survey showing interindividual variability among neurosurgeons when deciding on the radicality of surgical resection in glioblastoma highlight the need for more objective guidelines Autores: Capellades, J; Teixidor, P; Villalba, G; Hostalot, C; Plans, G; Armengol, R; Medrano, S; Estival, A; Luque, R; Gonzalez, S; Gil-Gil, M; Villa, S; Sepulveda, J; Garcia-Mosquera, JJ; Balana, C < 1 2 … 1.434 1.435 1.436 … 1.504 1.505 >